Literature DB >> 25482601

Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Ronald A Shikiya1, Thomas E Eckland, Alan J Young, Jason C Bartz.   

Abstract

Prion diseases are fatal transmissible neurodegenerative disorders that affect animals including humans. The kinetics of prion infectivity and PrP(Sc) accumulation can differ between prion strains and within a single strain in different tissues. The net accumulation of PrP(Sc) in animals is controlled by the relationship between the rate of PrP(Sc) formation and clearance. Protein misfolding cyclic amplification (PMCA) is a powerful technique that faithfully recapitulates PrP(Sc) formation and prion infectivity in a cell-free system. PMCA has been used as a surrogate for animal bioassay and can model species barriers, host range, strain co-factors and strain interference. In this study we investigated if degradation of PrP(Sc) and/or prion infectivity occurs during PMCA. To accomplish this we performed PMCA under conditions that do not support PrP(Sc) formation and did not observe either a reduction in PrP(Sc) abundance or an extension of prion incubation period, compared to untreated control samples. These results indicate that prion clearance does not occur during PMCA. These data have significant implications for the interpretation of PMCA based experiments such as prion amplification rate, adaptation to new species and strain interference where production and clearance of prions can affect the outcome.

Entities:  

Keywords:  prion clearance; prion disease; protein misfolding cyclic amplification

Mesh:

Substances:

Year:  2014        PMID: 25482601      PMCID: PMC4601219          DOI: 10.4161/19336896.2014.983759

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  66 in total

1.  The physical basis of how prion conformations determine strain phenotypes.

Authors:  Motomasa Tanaka; Sean R Collins; Brandon H Toyama; Jonathan S Weissman
Journal:  Nature       Date:  2006-06-28       Impact factor: 49.962

2.  Prion clearance in bigenic mice.

Authors:  Jiri G Safar; Stephen J DeArmond; Katarzyna Kociuba; Camille Deering; Svetlana Didorenko; Essia Bouzamondo-Bernstein; Stanley B Prusiner; Patrick Tremblay
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

3.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

4.  Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie.

Authors:  M Beekes; E Baldauf; H Diringer
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

5.  Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy.

Authors:  C I Lasmézas; J P Deslys; R Demaimay; K T Adjou; J J Hauw; D Dormont
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

6.  In vitro generation of infectious scrapie prions.

Authors:  Joaquín Castilla; Paula Saá; Claudio Hetz; Claudio Soto
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

7.  Strain-dependent differences in beta-sheet conformations of abnormal prion protein.

Authors:  B Caughey; G J Raymond; R A Bessen
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

8.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

View more
  5 in total

1.  Incongruity between Prion Conversion and Incubation Period following Coinfection.

Authors:  Katie A Langenfeld; Ronald A Shikiya; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

Review 2.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

3.  PrPSc formation and clearance as determinants of prion tropism.

Authors:  Ronald A Shikiya; Katie A Langenfeld; Thomas E Eckland; Jonathan Trinh; Sara A M Holec; Candace K Mathiason; Anthony E Kincaid; Jason C Bartz
Journal:  PLoS Pathog       Date:  2017-03-29       Impact factor: 6.823

Review 4.  Cellular and Molecular Mechanisms of Prion Disease.

Authors:  Christina J Sigurdson; Jason C Bartz; Markus Glatzel
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 32.350

5.  Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.

Authors:  Maxime Belondrade; Simon Nicot; Vincent Béringue; Joliette Coste; Sylvain Lehmann; Daisy Bougard
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.